Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)

BACKGROUND. This study aimed to evaluate the efficacy and toxicity of single-agent gemcitabine versus gemcitabine plus docetaxel as second-line therapy in patients with uterine and nonuterine leiomyosarcoma (LMS). PATIENTS AND METHODS. Patients had metastatic or unresectable LMS and had received one...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pautier, Patricia, Floquet, Anne, Penel, Nicolas, Piperno-Neumann, Sophie, Isambert, Nicolas, Rey, Annie, Bompas, Emmanuelle, Cioffi, Angela, Delcambre, Corinne, Cupissol, Didier, Collin, Françoise, Blay, Jean-Yves, Jimenez, Marta, Duffaud, Florence
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2012
Assuntos:
Sarcomas
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3448415/
https://ncbi.nlm.nih.gov/pubmed/22907974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0467
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados